Incyte Corporation (INCY) has recently garnered attention from Marc Frahm, an analyst at TD Cowen. In a report released yesterday, Frahm reaffirmed his "Buy" rating on the biopharmaceutical company, setting a price target of $88.00. This upbeat outlook comes as Incyte's shares closed...
DHS Launches Polygraph Tests toCombat Leaks of Immigration Raid Details
The Department of Homeland Security (DHS) has recently begun administering polygraph tests...
Ellesmere Park High School in Eccles, Salford, is facing criticism for its recent initiative to improve attendance, offering daily prize draws featuring vouchers as...
Discount retail giant Lidl has emerged victorious in its quest to establish a presence in Salford's Castle Irwell scheme. The triumph comes after facing...
Liverpool Council is exploring the possibility of transferring the management of two underperforming leisure centres to community groups, marking a significant shift in the...